Log in

Relevant bibliographies by topics / Protective Immunity

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Protective Immunity'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Protective Immunity.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Protective Immunity"

1

Burger, Eva. "Paracoccidioidomycosis Protective Immunity." Journal of Fungi 7, no. 2 (2021): 137. http://dx.doi.org/10.3390/jof7020137.

Full text

Abstract:

Protective immunity against Paracoccidioides consists of a stepwise activation of numerous effector mechanisms that comprise many cellular and soluble components. At the initial phase of non-specific innate immunity, resistance against Paracoccidioides comes from phagocytic polymorphonuclear neutrophils, natural killer (NK) cells and monocytes, supplemented by soluble factors such as cytokines and complement system components. Invariant receptors (Toll-like receptors (TLRs), Dectins) which are present in cells of the immune system, detect patterns present in Paracoccidioides (but not in the ho

APA, Harvard, Vancouver, ISO, and other styles

2

Hoerauf, Achim, and Cathy Steel. "3.2 PROTECTIVE IMMUNITY—VACCINES." American Journal of Tropical Medicine and Hygiene 71, no. 5_suppl (2004): 34–36. http://dx.doi.org/10.4269/ajtmh.2004.71.5_suppl.0700034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Cox, R. A., and D. M. Magee. "Protective immunity in coccidioidomycosis." Research in Immunology 149, no. 4-5 (1998): 417–28. http://dx.doi.org/10.1016/s0923-2494(98)80765-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Huang, Shou-Jie, Xiao-Hui Liu, Jun Zhang, and Mun-Hon Ng. "Protective immunity against HEV." Current Opinion in Virology 5 (April 2014): 1–6. http://dx.doi.org/10.1016/j.coviro.2013.10.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Zinkernagel, Rolf M. "Immunological memory ≠ protective immunity." Cellular and Molecular Life Sciences 69, no. 10 (2012): 1635–40. http://dx.doi.org/10.1007/s00018-012-0972-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lin, Wen-Hsuan, and Diane E. Griffin. "138 Understanding protective immunity." JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (April 2014): 58. http://dx.doi.org/10.1097/01.qai.0000446718.70725.4b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Watson, J. D. "Leprosy: understanding protective immunity." Immunology Today 10, no. 7 (1989): 218–21. http://dx.doi.org/10.1016/0167-5699(89)90253-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Watanabe, Mineo, and Masaaki Nagai. "Role of Systemic and Mucosal Immune Responses in Reciprocal Protection against Bordetella pertussis and Bordetella parapertussis in a Murine Model of Respiratory Infection." Infection and Immunity 71, no. 2 (2003): 733–38. http://dx.doi.org/10.1128/iai.71.2.733-738.2003.

Full text

Abstract:

ABSTRACT The roles of systemic humoral immunity, cell-mediated immunity, and mucosal immunity in reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis were examined by using a murine model of respiratory infection. Passive immunization with serum from mice infected with B. pertussis established protective immunity against B. pertussis but not against B. parapertussis. Protection against B. parapertussis was induced in mice that had been injected with serum from mice infected with B. parapertussis but not from mice infected with B. pertussis. Adoptive transfer

APA, Harvard, Vancouver, ISO, and other styles

9

Blutt, Sarah E., Kelly L. Warfield, Mary K. Estes, and Margaret E. Conner. "Differential Requirements for T Cells in Viruslike Particle- and Rotavirus-Induced Protective Immunity." Journal of Virology 82, no. 6 (2008): 3135–38. http://dx.doi.org/10.1128/jvi.01727-07.

Full text

Abstract:

ABSTRACT Correlates of protection from rotavirus infection are controversial. We compared the roles of B and T lymphocytes in protective immunity induced either by intranasally administered nonreplicating viruslike particles or inactivated virus or by orally administered murine rotavirus. We found that protection induced by nonreplicating vaccines requires CD4+ T cells and CD40/CD40L. In contrast, T cells were not required for short-term protective immunity induced by infection, but both T-cell-dependent and -independent mechanisms contributed to long-term maintenance of protection. Our findin

APA, Harvard, Vancouver, ISO, and other styles

10

Mokaya, Jolynne, Derick Kimathi, Teresa Lambe, and George M. Warimwe. "What Constitutes Protective Immunity Following Yellow Fever Vaccination?" Vaccines 9, no. 6 (2021): 671. http://dx.doi.org/10.3390/vaccines9060671.

Full text

Abstract:

Yellow fever (YF) remains a threat to global health, with an increasing number of major outbreaks in the tropical areas of the world over the recent past. In light of this, the Eliminate Yellow Fever Epidemics Strategy was established with the aim of protecting one billion people at risk of YF through vaccination by the year 2026. The current YF vaccine gives excellent protection, but its use is limited by shortages in supply due to the difficulties in producing the vaccine. There are good grounds for believing that alternative fractional dosing regimens can produce strong protection and overc

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Protective Immunity"

1

Al-Dahwi, Zaineb. "Impairment of protective immunity to intestinal helminthiases." To access this resource online via ProQuest Dissertations and Theses @ UTEP, 2007. http://0-proquest.umi.com.lib.utep.edu/login?COPT=REJTPTU0YmImSU5UPTAmVkVSPTI=&clientId=2515.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ronan, Edward. "Understanding vaccine induced protective immunity to Mycobacterium tuberculosis." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:c0d7b20f-e144-42f8-aa52-301d0938b0b3.

Full text

Abstract:

The current worldwide epidemic of Mycobacterium tuberculosis infection is a huge global health problem. Widespread BCG vaccination remains a useful tool in combating this epidemic; however, its variable efficacy requires urgent development of novel vaccines against Mycobacterium tuberculosis. Such a candidate vaccine is a serotype 5 adenovirus expressing antigen 85A from M. tuberculosis (Ad85A). In animal models Ad85A confers significant protection when administered intra-nasally. The work in this thesis demonstrates that intra-nasal immunisation with Ad85A results in inhibition of M. tubercul

APA, Harvard, Vancouver, ISO, and other styles

3

Yu-Lin, Teoh. "Programming CD8 T cell memory development and protective immunity." Thesis, University of Oxford, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.491759.

Full text

Abstract:

In order to elicit the ideal set of memory CD8 T cells, rational vaccine design and planning for vaccination regimes require additional knowledge on factors which affect CD8 memory development. Together with the initial conditions under which priming occurs, aspects upstream of the CD8 response such as antigen processing, trafficking and presentation have the ability to influence both the development of the response as well as the type of memory population generated. The exceptional influence of these factors on the resultant CD8 T cell response has led to the concept of CD8 T cell programming

APA, Harvard, Vancouver, ISO, and other styles

4

Hicks, Alice Sophie. "Defining biomarkers of protective immunity and disease for tuberculosis." Thesis, St George's, University of London, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.589943.

Full text

Abstract:

Tuberculosis (TB) is still a significant global public health problem. The only current vaccine, BCG, gives variable protection, especially in adults. Several new vaccines are currently in clinical trials but no correlates of protective immunity to TB have been defined. Therefore, vaccines have to go through extensive pre-clinical assessments and clinical trials. Once identified, correlates of protection could be used as early end-points during clinical trials, reducing costs and easing the assessment of a greater number of vaccine candidates. In addition, more reliable biomarkers of TB diseas

APA, Harvard, Vancouver, ISO, and other styles

5

Vento, Kevin Leon. "Assessment of protective immunity following mucosal vaccination with Pseudomonas aeruginosa." Thesis, St George's, University of London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.408031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kamuyu, Gathoni. "Identifying merozoite targets of protective immunity against Plasmodium falciparum malaria." Thesis, Open University, 2017. http://oro.open.ac.uk/51139/.

Full text

Abstract:

The observation that individuals living in malaria endemic regions who are repeatedly infected with <i>P. falciparum</i> can acquire immunity, first to severe, then to uncomplicated clinical episodes of malaria, and finally to high parasite densities, provides hope that a vaccine is achievable. Immunoglobulins have been identified as a key component of naturally acquired immunity and identifying the targets and mechanisms by which this protection is achieved is a clear research priority. To date, only a small proportion of the parasite proteome has been evaluated in the context of naturally ac

APA, Harvard, Vancouver, ISO, and other styles

7

Carrillo, Martha. "Studies on protective immunity to toxocara canis in laboratory animals /." The Ohio State University, 1989. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487671108307319.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Scheckelhoff, Mark R. "Specific T cell repertoires mediate protective immunity to Histoplasma capsulatum." Cincinnati, Ohio : University of Cincinnati, 2003. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=ucin1051292258.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bereczky, Sándor. "Genetic diversity of Plasmodium falciparum infections : influence on protective malaria immunity /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-548-8/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ali, Pirlanta Omer. "Schistosoma mansoni schistosomulum surface epitopes and their relevance to protective immunity." Thesis, Brunel University, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.253289.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Protective Immunity"

1

Ali, Pirlanta Omer. Schistosoma mansoni: Schistosomulum surface epitopes and their relevance to protective immunity. Brunel University, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Special Programme for Research and Training in Tropical Diseases. Scientific Working Group on Filariasis., ed. Protective immunity and vaccination in onchocerciasis and lymphatic filariasis: Report of the thirteenth meeting of the Scientific Working Group on Filariasis. World Health Organization, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Thompson, Bridget. Murine acute myeloid leukemia cells expressing the cytosine deaminase gene induce protective immunity to parental leukemic cells. National Library of Canada, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Igor, Primoratz, ed. Civilian immunity in war. Oxford University Press, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Friedlander, Mark P. Winning the war within: Understanding, protecting, and building your body's immunity. Rodale Press, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

1939-, Eichmann Klaus, ed. The biology of complex organisms: Creation and protection of integrity. Birkhauser Verlag, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Klatz, Ronald. Infection protection: How to fight the germs that make you sick. HarperResource, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Jha, R. C. Fundamental rights and doctrine of sovereign immunity: Reflections on the Indian Constitution for the protection of human rights. Sheridan Book Co., 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Aguzarov, T. K. Prestupnye posi︠a︡gatelʹstva na nezavisimostʹ i neprikosnovennostʹ sudeĭ: Monografii︠a︡. Prospekt, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Candrian, Jérôme. L'immunité des États face aux droits de l'homme et à la protection des biens culturels: Immunité de juridiction des États et droits de l'homme, immunité d'exécution des États et de leurs biens culturels. Schulthess, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Protective Immunity"

1

Zhang, Guoquan, Yan Zhang, and James E. Samuel. "Components of Protective Immunity." In Advances in Experimental Medicine and Biology. Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-94-007-4315-1_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cornelius, Claire, Olaf Schneewind, Deborah Anderson, and Lauriane Quenee. "Protective Immunity Against Plague." In Advances In Experimental Medicine And Biology. Springer New York, 2007. http://dx.doi.org/10.1007/978-0-387-72124-8_38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Khanna, Nina, and Claudia Stuehler. "T-Cell-Mediated Cross-Protective Immunity." In Methods in Molecular Biology. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7104-6_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hayashi, Tomoko, Christine H. Tran, Lucinda Beck, Savita Rao, and Antonino Catanzaro. "Protective Immunity of Immunostimulatory Sequences Against Mycobacterial Infection." In Microbial DNA and Host Immunity. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-305-7_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Robbins, John B., Rachel Schneerson, and Shousun C. Szu. "Hypothesis: How Licensed Vaccines Confer Protective Immunity." In Advances in Experimental Medicine and Biology. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4899-1382-1_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Shahin, Roberta D., ChrisAnna Mink, Bernhard L. Wiedermann, and Bruce D. Meade. "Laboratory Correlates of Protection and Protective Immunity to Bordetella Pertussis." In Genetically Engineered Vaccines. Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3410-5_30.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Milligan, Gregg N. "The Host Immune Response, Protective Immunity, and Correlates of Protection." In Vaccinology. John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118638033.ch5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Jarra, W. "Protective Immunity to Malaria and Anti-Erythrocyte Autoimmunity." In Novartis Foundation Symposia. John Wiley & Sons, Ltd., 2008. http://dx.doi.org/10.1002/9780470715444.ch9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sylvestre, Patricia, Ian Justin Glomski, Evelyne Couture-Tosi, Pierre Louis Goossens, and Michèle Mock. "Spore Surface Components and Protective Immunity to Bacillus anthracis." In National Institute of Allergy and Infectious Diseases, NIH. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-569-5_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hanekom, Willem A., and Joel D. Ernst. "Maintenance of Latent Infection, with Correlates of Protective Immunity." In Handbook of Tuberculosis. Wiley-VCH Verlag GmbH & Co. KGaA, 2017. http://dx.doi.org/10.1002/9783527611614.ch28.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Protective Immunity"

1

Garman, Faraj A. "Can Zinc Prevent Corrosion of Pre-Stressed Concrete Cylinder Pipes in High Resistivity Soils?" In CORROSION 2008. NACE International, 2008. https://doi.org/10.5006/c2008-08055.

Full text

Abstract:

Abstract Zinc sacrificial anodes are not generally recommended to be used for the protection of steel in high resistivity soils (&gt;1500 Ω.cm) as the driving potential of the zinc will not be sufficient to provide the required current needed to drive the structure to soil potential to the protection criterion of -850 mV w.r.t. Cu/CuSO4. This criterion guarantees that the structure potential is shifted from the active region to the immunity region of the potential-pH diagram, where the corrosion process is to be completely halted. Generally, more than 300 mV of negative shift is required.

APA, Harvard, Vancouver, ISO, and other styles

2

Kajiyama, Fumio. "Achievement of Cathodic Protection of Buried Steel Pipelines by Either Passivity or Immunity." In CORROSION 2017. NACE International, 2017. https://doi.org/10.5006/c2017-08829.

Full text

Abstract:

Abstract Corrosion control of steel pipelines in soils can be achieved by cathodic protection (CP) to make either passivity or immunity of the steel surface.1 Passivation and immunity domains are depicted by potential-pH diagram presented by M. Pourbaix.2 This paper elucidates the behavior of CP in passivation and immunity domains, respectively, by considering the relation between polarized potential and pH at the steel/soil interface. As an example of corrosion protection in passivation domain, steel in aerobic sand containing iron bacteria (IB) was taken. Steel in anaerobic clay containing a

APA, Harvard, Vancouver, ISO, and other styles

3

Kircher, Daniel, Cristian Ionascu, and Bernd Deutschmann. "Electromagnetic Immunity of the Overtemperature Protection of Smart Power High Side Switches." In 2024 International Symposium on Electromagnetic Compatibility – EMC Europe. IEEE, 2024. http://dx.doi.org/10.1109/emceurope59828.2024.10722128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hilger, U., S. Miropolsky, and S. Frei. "Modeling of Automotive Bus Transceivers and ESD Protection Circuits for Immunity Simulations of Extended Networks." In 2010_EMC-Europe_Wroclaw. IEEE, 2010. https://doi.org/10.23919/emc.2010.10826177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Fallahmohammadi, E., P. Anelli, R. Sica, and F. Casiraghi. "Corrosion and SSC Resistant Cladding Material for H2S/CO2 Oil and Gas Containing Environment." In CORROSION 2018. NACE International, 2018. https://doi.org/10.5006/c2018-11070.

Full text

Abstract:

Abstract For the first phase of the Project solution has been developed to overcome sulfide stress corrosion problems in high strength steel armors in H2S/CO2 containing environment. The solution consists of protecting high strength steel armor elements with an aluminum cladding produced by method of Conform. This cladding has been shown to be fully H2S tolerant and capable to maintain bare steel in condition of electrochemical immunity (cathodic protection). The present paper summarizes the theoretical framework and the test programs worked out to validate the aluminum cladding solution. Resu

APA, Harvard, Vancouver, ISO, and other styles

6

Olivo, Juan Dominguez, Terry Natale, and Sujay Math. "Electrochemical Investigation of the Integrity of Cathodic Protection MMO Anodes in the Presence of Vapor Corrosion Inhibitors." In CONFERENCE 2024. AMPP, 2024. https://doi.org/10.5006/c2024-21177.

Full text

Abstract:

Abstract Cathodic protection (CP) technology is widely utilized to safeguard aboveground storage tanks (ASTs) against soil-side corrosion, with the U.S. Department of Transportation mandating the implementation of CP systems for ASTs governed by federal regulations. CP is typically applied to the new ASTs bottom through the installation of anodes under the tanks. The anodic portion of impressed current cathodic protection (ICCP) systems consists of titanium conductor bars and mixed metal oxide (MMO) anodes which are embedded in the sand bed a few inches below the new bottoms. To enhance the so

APA, Harvard, Vancouver, ISO, and other styles

7

Esaklul, Khlefa A., and John W. Martin. "High Strength Fasteners for Subsea Applications." In CORROSION 2004. NACE International, 2004. https://doi.org/10.5006/c2004-04151.

Full text

Abstract:

Abstract Mechanical properties, corrosion resistance and immunity to environmentally assisted cracking are the key elements in selection of fasteners for sub-sea applications. While corrosion resistance and mechanical properties are attainable, finding materials that offer resistance to cracking in seawater service in areas of intense cathodic polarization or in galvanically coupled systems has been a major challenge. High strength low alloy steels have had acceptable performance in cathodically protected systems. Their applications have been limited to maximum yield strength of 140 ksi (965 M

APA, Harvard, Vancouver, ISO, and other styles

8

Dranoff, Glenn. "Abstract IA25: Mechanisms of protective tumor immunity." In Abstracts: AACR Special Conference: Tumor Immunology and Immunotherapy: A New Chapter; December 1-4, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/2326-6074.tumimm14-ia25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Dranoff, Glenn. "Abstract PL07-03: Mechanisms of protective tumor immunity." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-pl07-03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Konyakhina, Yu V., A. A. Sergeev, K. A. Titova, S. A. Pyankov, S. N. Yakubitskiy, and S. N. Shchelkunov. "LOW-DOSE SMALLPOX VACCINATION IN A MOUSE MODEL." In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-254.

Full text

Abstract:

Vaccinia virus (VACV) strains caused a more pronounced production of antibodies with intradermal (i.d.) injection compared to scarification (s.s.) inoculation. To test for developed protective immunity at 62 day post vaccination (dpv), mice were intranasally infected with a cowpox virus. The results showed that i.d. injection provided the development of protective immunity in mice to a much greater extent compared to s.s. inoculation with VACV strains.

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Protective Immunity"

1

Jones, Trevor R., W. R. Ballou, and Stephen L. Hoffman. Antibodies to the Circumsporozoite Protein and Protective Immunity to Malaria Sporozoites. Defense Technical Information Center, 1993. http://dx.doi.org/10.21236/ada266478.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lillehoj, Hyun, Dan Heller, and Mark Jenkins. Cellular and molecular identification of Eimeria Acervulina Merozoite Antigens eliciting protective immunity. United States Department of Agriculture, 1992. http://dx.doi.org/10.32747/1992.7561056.bard.

Full text

Abstract:

Coccidiosis, ubiquitous diseases of poultry, seriously impair the growth and feed utilization of livestock and poultry. Coccidiosis causes over $600 million annual losses world-wide and no vaccine is currently available. The goal of this study was to investigate the cellular and molecular mechanisms controlling protective immune responses to coccidia parasites in order to develop immunological control strategy against coccidiosis. The major findings of this study were: 1) cell-mediated immunity plays a major role in protection against coccidiosis, 2) when different genetic lines showing differ

APA, Harvard, Vancouver, ISO, and other styles

3

Klinman, Dennis M. Rapid Induction of Protective Immunity Against Biothreat Agents Using CPG-Based Oligonucleotides. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada417843.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Banai, Menachem, and Gary Splitter. Molecular Characterization and Function of Brucella Immunodominant Proteins. United States Department of Agriculture, 1993. http://dx.doi.org/10.32747/1993.7568100.bard.

Full text

Abstract:

The BARD project was a continuation of a previous BARD funded research project. It was aimed at characterization of the 12kDa immunodominant protein and subsequently the cloning and expression of the gene in E. coli. Additional immunodominant proteins were sought among genomic B. abortus expression library clones using T-lymphocyte proliferation assay as a screening method. The 12kDa protein was identified as the L7/L12 ribosomal protein demonstrating in the first time the role a structural protein may play in the development of the host's immunity against the organism. The gene was cloned fro

APA, Harvard, Vancouver, ISO, and other styles

5

Baszler, Timothy, Igor Savitsky, Christopher Davies, Lauren Staska, and Varda Shkap. Identification of bovine Neospora caninum cytotoxic T-lymphocyte epitopes for development of peptide-based vaccine. United States Department of Agriculture, 2006. http://dx.doi.org/10.32747/2006.7695592.bard.

Full text

Abstract:

The goal of the one-year feasibility study was to identify specific cytotoxic T-lymphocyte (CTL) epitopes to Neosporacaninum in the natural bovine host in order to make progress toward developing an effective peptide-based vaccine against bovine neosporosis. We tested the hypothesis that: N. caninum SRS2 peptides contain immunogenicCTLepitope clusters cross-presented by multiple bovine MHC-I and MHC-IIhaplotypes. The specific objectives were: (1) Map bovine CTLepitopes of N. caninum NcSRS-2 and identify consensus MHC-I and class-II binding motifs; and (2) Determine if subunit immunization with

APA, Harvard, Vancouver, ISO, and other styles

6

McElwain, Terry F., Eugene Pipano, Guy H. Palmer, Varda Shkap, Stephn A. Hines, and Wendy C. Brown. Protection of Cattle against Babesiosis: Immunization against Babesia bovis with an Optimized RAP-1/Apical Complex Construct. United States Department of Agriculture, 1999. http://dx.doi.org/10.32747/1999.7573063.bard.

Full text

Abstract:

Previous research and current efforts at control of babesiosis fall short of meeting the needs of countries where the disease is endemic, such as Israel, as well as the needs of exporting countries and countries bordering on endemic areas, such as the U.S. Our long-term goal is to develop improved methods of immunization against bovine babesiosis based on an understanding of the molecular mechanisms of immune protection and parasite targets of a protective immune response. In our previous BARD project, we established the basis for focusing on rhoptry antigens as components of a subunit vaccine

APA, Harvard, Vancouver, ISO, and other styles

7

Bercovier, Herve, Raul Barletta, and Shlomo Sela. Characterization and Immunogenicity of Mycobacterium paratuberculosis Secreted and Cellular Proteins. United States Department of Agriculture, 1996. http://dx.doi.org/10.32747/1996.7573078.bard.

Full text

Abstract:

Our long-term goal is to develop an efficient acellular vaccine against paratuberculosis based on protein antigen(s). A prerequisite to achieve this goal is to analyze and characterize Mycobacterium paratuberculosis (Mpt) secreted and cellular proteins eliciting a protective immune response. In the context of this general objective, we proposed to identify, clone, produce, and characterize: the Mpt 85B antigen and other Mpt immunoreactive secreted proteins, the Mpt L7/L12 ribosomal protein and other immunoreactive cellular proteins, Mpt protein determinants involved in invasion of epithelial c

APA, Harvard, Vancouver, ISO, and other styles

8

Brayton, Kelly A., Varda Shkap, Guy H. Palmer, Wendy C. Brown, and Thea Molad. Control of Bovine Anaplasmosis: Protective Capacity of the MSP2 Allelic Repertoire. United States Department of Agriculture, 2014. http://dx.doi.org/10.32747/2014.7699838.bard.

Full text

Abstract:

Anaplasmosis is an arthropod-borne disease of cattle caused by the rickettsia Anaplasmamarginale and is an impediment to efficient production of healthy livestock in both Israel and the United States. Currently, the only effective vaccines are derived from the blood of infected cattle. The risk of widespread transmission of both known and newly emergent pathogens has prevented licensure of live blood-based vaccines in the U.S. and is a major concern for their continued use in Israel. Consequently, development of a safe, effective vaccine is a high priority. Despite its drawbacks as a live, blo

APA, Harvard, Vancouver, ISO, and other styles

9

Knowles, Donald, and Monica Leszkowicz Mazuz. Transfected Babesia bovis expressing the anti-tick Bm86 antigen as a vaccine to limit tick infestation and protect against virulent challenge. United States Department of Agriculture, 2014. http://dx.doi.org/10.32747/2014.7598160.bard.

Full text

Abstract:

Bovine babesiosis, caused by the apicomplexan parasites Babesiabovisand B. bigemina, is a major tick borne disease of cattle with significant economic importance globally. The vectors of Babesia parasites are R. (Boophilus) annulatusand R. microplus. In Israel these parasites are transmitted manly by R. annulatus. The main goal of the proposal was developing and testing a novel B. bovisvaccine based on stably transfected attenuated B. bovisexpressing the anti-tick Bm86 antigen. This required generating a transfected- attenuated B. bovisparasite containing a bidirectional promoter expressing bo

APA, Harvard, Vancouver, ISO, and other styles

10

Bunn, Sarah. Immunity to COVID-19. Parliamentary Office of Science and Technology, 2020. http://dx.doi.org/10.58248/rr30.

Full text

Abstract:

Scientific understanding of the immune response to COVID-19 is incomplete but numerous research studies are underway. There is little evidence to suggest that exposure to other coronaviruses can confer protection against SARS-CoV-2. There is very good evidence that it takes at least 14 days to develop an antibody response to SARS-CoV-2. A significant proportion of people exposed to SARS-CoV-2 make very little or no detectable antibodies at all. There is insufficient scientific evidence to know whether the presence of SARS-CoV-2 antibodies confers protection from subsequent infections, and if s

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!